IL6 and fatty liver disease: Reportedly, anti-inflammatory effects of bilirubin played vital roles in reducing pro-inflammatory cytokines production, such as interleukin-6, interleukin-1, which had been found to contribute to hepatic steatosis in the murine model of NAFLD47.